These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
281 related articles for article (PubMed ID: 26080461)
21. Implications of antiviral resistance of influenza viruses. Monto AS Clin Infect Dis; 2009 Feb; 48(4):397-9. PubMed ID: 19586376 [No Abstract] [Full Text] [Related]
22. Differential localization and function of PB1-F2 derived from different strains of influenza A virus. Chen CJ; Chen GW; Wang CH; Huang CH; Wang YC; Shih SR J Virol; 2010 Oct; 84(19):10051-62. PubMed ID: 20660199 [TBL] [Abstract][Full Text] [Related]
23. Identification of a novel small-molecule compound targeting the influenza A virus polymerase PB1-PB2 interface. Yuan S; Chu H; Ye J; Singh K; Ye Z; Zhao H; Kao RY; Chow BK; Zhou J; Zheng BJ Antiviral Res; 2017 Jan; 137():58-66. PubMed ID: 27840201 [TBL] [Abstract][Full Text] [Related]
24. Amantadine resistance among porcine H1N1, H1N2, and H3N2 influenza A viruses isolated in Germany between 1981 and 2001. Schmidtke M; Zell R; Bauer K; Krumbholz A; Schrader C; Suess J; Wutzler P Intervirology; 2006; 49(5):286-93. PubMed ID: 16809934 [TBL] [Abstract][Full Text] [Related]
25. Packaging signals in the 5'-ends of influenza virus PA, PB1, and PB2 genes as potential targets to develop nucleic-acid based antiviral molecules. Giannecchini S; Wise HM; Digard P; Clausi V; Del Poggetto E; Vesco L; Puzelli S; Donatelli I; Azzi A Antiviral Res; 2011 Oct; 92(1):64-72. PubMed ID: 21741410 [TBL] [Abstract][Full Text] [Related]
26. miR-193b represses influenza A virus infection by inhibiting Wnt/β-catenin signalling. Yang X; Zhao C; Bamunuarachchi G; Wang Y; Liang Y; Huang C; Zhu Z; Xu D; Lin K; Senavirathna LK; Xu L; Liu L Cell Microbiol; 2019 May; 21(5):e13001. PubMed ID: 30650225 [TBL] [Abstract][Full Text] [Related]
27. Avian Influenza Virus PB1 Gene in H3N2 Viruses Evolved in Humans To Reduce Interferon Inhibition by Skewing Codon Usage toward Interferon-Altered tRNA Pools. Smith BL; Chen G; Wilke CO; Krug RM mBio; 2018 Jul; 9(4):. PubMed ID: 29970470 [TBL] [Abstract][Full Text] [Related]
28. A comprehensive surveillance of adamantane resistance among human influenza A virus isolated from mainland China between 1956 and 2009. Lan Y; Zhang Y; Dong L; Wang D; Huang W; Xin L; Yang L; Zhao X; Li Z; Wang W; Li X; Xu C; Yang L; Guo J; Wang M; Peng Y; Gao Y; Guo Y; Wen L; Jiang T; Shu Y Antivir Ther; 2010; 15(6):853-9. PubMed ID: 20834097 [TBL] [Abstract][Full Text] [Related]
29. High resolution melting analysis as a tool to detect molecular markers of antiviral resistance in influenza A viruses. Arvia R; Corcioli F; Azzi A J Virol Methods; 2013 May; 189(2):265-70. PubMed ID: 23499313 [TBL] [Abstract][Full Text] [Related]
31. Altered viral replication and cell responses by inserting microRNA recognition element into PB1 in pandemic influenza A virus (H1N1) 2009. Shen X; Sun W; Shi Y; Xing Z; Su X Mediators Inflamm; 2015; 2015():976575. PubMed ID: 25788763 [TBL] [Abstract][Full Text] [Related]
32. Anti-influenza virus activity of a salcomine derivative mediated by inhibition of viral RNA synthesis. Takizawa N; Kimura T; Watanabe T; Shibasaki M Arch Virol; 2018 Jun; 163(6):1607-1614. PubMed ID: 29497849 [TBL] [Abstract][Full Text] [Related]
33. Human miR-5193 Triggers Gene Silencing in Multiple Genotypes of Hepatitis B Virus. Khlaiphuengsin A; T-Thienprasert NP; Tangkijvanich P; Posuwan N; Makkoch J; Poovorawan Y; Payungporn S Microrna; 2015; 4(2):123-30. PubMed ID: 26456535 [TBL] [Abstract][Full Text] [Related]
34. A novel benzo-heterocyclic amine derivative N30 inhibits influenza virus replication by depression of Inosine-5'-Monophospate Dehydrogenase activity. Hu J; Ma L; Wang H; Yan H; Zhang D; Li Z; Jiang J; Li Y Virol J; 2017 Mar; 14(1):55. PubMed ID: 28298229 [TBL] [Abstract][Full Text] [Related]
35. The avian-origin PB1 gene segment facilitated replication and transmissibility of the H3N2/1968 pandemic influenza virus. Wendel I; Rubbenstroth D; Doedt J; Kochs G; Wilhelm J; Staeheli P; Klenk HD; Matrosovich M J Virol; 2015 Apr; 89(8):4170-9. PubMed ID: 25631088 [TBL] [Abstract][Full Text] [Related]
36. Inhibition of influenza A virus replication by antagonism of a PI3K-AKT-mTOR pathway member identified by gene-trap insertional mutagenesis. Murray JL; McDonald NJ; Sheng J; Shaw MW; Hodge TW; Rubin DH; O'Brien WA; Smee DF Antivir Chem Chemother; 2012 May; 22(5):205-15. PubMed ID: 22374988 [TBL] [Abstract][Full Text] [Related]
37. Infection of human retinal pigment epithelial cells with influenza A viruses. Michaelis M; Geiler J; Klassert D; Doerr HW; Cinatl J Invest Ophthalmol Vis Sci; 2009 Nov; 50(11):5419-25. PubMed ID: 19553611 [TBL] [Abstract][Full Text] [Related]
38. Genetic characterization of circulating seasonal Influenza A viruses (2005-2009) revealed introduction of oseltamivir resistant H1N1 strains during 2009 in eastern India. Agrawal AS; Sarkar M; Ghosh S; Roy T; Chakrabarti S; Lal R; Mishra AC; Chadha MS; Chawla-Sarkar M Infect Genet Evol; 2010 Dec; 10(8):1188-98. PubMed ID: 20678590 [TBL] [Abstract][Full Text] [Related]
39. [Design of deoxyribozymes for inhibition of influenza A virus]. Evdokimov AA; Mazurkova NA; Malygin EG; Zarytova VF; Levina AS; Repkova MN; Zagrebelnyĭ SN; Netesova NA Mol Biol (Mosk); 2013; 47(1):83-93. PubMed ID: 23705497 [TBL] [Abstract][Full Text] [Related]
40. Antiviral activity of SA-2 against influenza A virus in vitro/vivo and its inhibition of RNA polymerase. Yu J; Wang D; Jin J; Xu J; Li M; Wang H; Dou J; Zhou C Antiviral Res; 2016 Mar; 127():68-78. PubMed ID: 26802558 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]